Stocks and Investing Stocks and Investing
Wed, March 20, 2013

Andrew Peters Maintained (BMRN) at Hold with Increased Target to $59 on, Mar 20th, 2013


Published on 2024-10-25 02:13:35 -
  Print publication without navigation


Andrew Peters of Deutsche Bank, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Hold with Increased Target from $45 to $59 on, Mar 20th, 2013.

Andrew has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $71 on, Tuesday, February 12th, 2013
  • Martin Auster of "UBS" Maintained at Strong Buy with Increased Target to $67 on, Friday, February 1st, 2013